New Delhi: Government Scientific Advisory Group About Covid-19 Immunization Still evaluates if different covid vaccine doses can be mixed for the dose of preventive measures (booster) but will come out with the final guidelines before January 10, when the power of health and frontline rs and they are above 60 With comorbidity can start receiving shots.
“We experience a broad debate about …
what vaccines are available and which vaccines can be given in terms of security and efficacy.
We analyze all available data …
whether it will be the same vaccine or it will be different,” Director said General ICMR Balram Bhargava.
“Medicines for Indian control and national technical advisory groups on immunization are meetings and decisions will be taken before January 10,” he said.
While clinical trials on mixing vaccine doses for booster in India have not been convincing, experts are considering international data, other officials said.
“International data shows a mixing of certain vaccines can produce high reactogity.
Although certain countries have mixed vaccines, many of them watch waves.
We must evaluate all aspects, it is not an easy decision,” said a senior official to Ti.
At present, India has only covishield and covaxin under the Government Covid Immunization Program.
However, the authorization of emergency use has been given to six others – Serum Institute of India Covovax, Corbevax E’s Biology, Russia Sputnik-V, Zycov-D Cadila Healthcare and two other Jabs from Moderna and Johnson & Johnson.
While CMC, Vellore is conducting a trial to test the mixing of covishield and covaxin doses, SII also conducts trials to test covavaks booster more than two doses of covishield.
In addition, the recent regulator gave permission to biological E to test Corbevax as a booster on two doses of covishield and covaxin.